2289 logo

Charmacy Pharmaceutical Co., Ltd. Stock Price

SEHK:2289 Community·HK$670.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

2289 Share Price Performance

HK$0
-9.00 (-100.00%)
HK$0
-9.00 (-100.00%)
Price HK$0

2289 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Fair value with mediocre balance sheet.

3 Risks
1 Reward

Charmacy Pharmaceutical Co., Ltd. Key Details

CN¥4.2b

Revenue

CN¥3.9b

Cost of Revenue

CN¥312.6m

Gross Profit

CN¥264.3m

Other Expenses

CN¥48.3m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
0.45
7.37%
1.14%
198.3%
View Full Analysis

About 2289

Founded
1984
Employees
849
CEO
Chuanglong Yao
WebsiteView website
www.chmyy.com

Charmacy Pharmaceutical Co., Ltd. engages in the pharmaceutical distribution business in the People’s Republic of China. The company distributes western medicines, Chinese patent medicines, healthcare products, and pharmaceutical products to downstream distributors and retail terminals. It also offers pharmaceutical product related consulting services; and operates Charmacy e-Medicine, a B2B e-commerce platform to place orders online, make inquires and payments, etc. The company was formerly known as Chuangmei Pharmaceutical Co., Ltd. and changed its name to Charmacy Pharmaceutical Co., Ltd. in July 2016. Charmacy Pharmaceutical Co., Ltd. was incorporated in 1984 and is based in Shantou, the People’s Republic of China.

Recent 2289 News & Updates

Recent updates

No updates